Cyclic helix B peptide ameliorates renal tubulointerstitial fibrosis induced by unilateral ureter obstruction via inhibiting NLRP3 pathway

BACKGROUND: Renal fibrosis is the inevitable outcome of all progressive chronic kidney diseases (CKD) and leads to a gradual loss of renal function. We previously reported cyclic helix B peptide (CHBP), a novel synthesized peptide derived from erythropoietin, had shown effective renoprotection. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Ruochen, Zhang, Weitao, Zheng, Long, Xu, Ming, Rong, Ruiming, Zhu, Tongyu, Yang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154394/
https://www.ncbi.nlm.nih.gov/pubmed/32309314
http://dx.doi.org/10.21037/atm.2020.02.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154394/
https://www.ncbi.nlm.nih.gov/pubmed/32309314
http://dx.doi.org/10.21037/atm.2020.02.12

Ejemplares similares